Lily Tang
About Lily Tang
Lily Tang is a Director of Biostatistics at Nektar Therapeutics, where she has worked since 2021. She has extensive experience in biostatistics, having held various positions at PPD, Kite Pharma, and Nektar Therapeutics over the past several years.
Current Role at Nektar Therapeutics
Lily Tang serves as the Director of Biostatistics at Nektar Therapeutics, a position she has held since 2021. In this role, she oversees biostatistical activities and contributes to the design and analysis of clinical trials. Her expertise in biostatistics supports the development of innovative therapies at the company.
Previous Experience at Nektar Therapeutics
Prior to her current role, Lily Tang worked at Nektar Therapeutics as the Associate Director of Biostatistics from 2020 to 2021. During her tenure, she played a key role in statistical analysis and contributed to the strategic planning of clinical studies.
Experience at Kite Pharma
Lily Tang was employed at Kite Pharma as a Senior Manager from 2018 to 2020. In this position, she managed biostatistical functions and collaborated with cross-functional teams to ensure the successful execution of clinical trials.
Education and Academic Background
Lily Tang earned her Bachelor's degree in Mathematics from Zhejiang University, where she studied from 2001 to 2006. She furthered her education at Penn State University, obtaining a Doctor of Philosophy (PhD) in Statistics from 2002 to 2007. Her academic background provides a strong foundation for her work in biostatistics.
Career Progression at PPD
Lily Tang has extensive experience at PPD, where she held multiple roles over several years. She served as a Senior Biostatistician from 2007 to 2013, then progressed to Biostatistics Team Leader from 2013 to 2016, and later worked as a Manager from 2016 to 2018. Her roles involved leading statistical teams and managing biostatistical projects.